Brief: Sio Gene Therapies Reports Q2 Loss Per Share Of $0.29
12/11/2021 12:50
Nov 12 (Reuters) - Sio Gene Therapies Inc SIOX.O :
* Q2 LOSS PER SHARE $0.29
* ESTIMATE THAT CURRENT CASH AND CASH EQUIVALENTS WILL
SUSTAIN
OPERATIONS INTO CALENDAR Q4 2022
* Q2 EARNINGS PER SHARE VIEW $-0.17 -- REFINITIV IBES DATA
Source text for Eikon: ID:nGNX1h8PfY
Further company coverage: SIOX.O
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Sio Gene Therapies
See all newsBrief: Sio Gene Therapies Inc - On March 14, Got Notice That Nasdaq Has Determined That Company's Common Stock Will Be Delisted From Nasdaq Capital Market
Brief: Sio Gene Therapies Announces Fiscal Third Quarter 2022 Financial Results
Brief: Sio Gene Therapies Inc. Announces Board Approval Of Plan Of Complete Liquidation, Dissolution
Brief: Sio Gene Therapies Announces Second Quarter Financial Results
Brief: Sio Gene Therapies Announces Fiscal First Quarter 2022 Financial Results